Management of anterior chamber dislocation of a dexamethasone intravitreal implant: A case report

被引:0
|
作者
Pacella F. [1 ]
Agostinelli E. [2 ]
Carlesimo S.C. [1 ]
Nebbioso M. [1 ]
Secondi R. [1 ]
Forastiere M. [1 ]
Pacella E. [1 ]
机构
[1] Department of Sense Organs, Faculty of Medicine and Dentistry, Sapienza University of Rome, Viale del Policlinico, Rome
[2] Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome
关键词
Case report; Cystoid macular edema; Intravitreal dexamethasone implant; Ozurdex; Ozurdex dislocation;
D O I
10.1186/s13256-016-1077-2
中图分类号
学科分类号
摘要
Background: Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon complication of the intravitreal injection, which can be managed by repositioning the implant into the vitreous cavity. We describe the case of a successful repositioning of an Ozurdex implant by mobilization and subsequent balanced saline solution injection in the anterior chamber. Case presentation: An 83-year-old white woman presented to our Emergency Unit complaining of pain and vision loss in herright eye lasting a week. Her anamnesis revealed a history of persistent cystoid macular edema after phacoemulsification with scleral-fixated posterior chamber intraocular lens implantation, recently treated with an intravitreal Ozurdex implant. She also took a long-distance flight 2 days after the injection. An anterior segment examination showed corneal edema and the rod implant adherent to corneal endothelium. To avoid corneal decompensation, we opted for a implant repositioning. Under topical anesthesia, a 30-gauge needle was introduced through a limbar incisionto mobilize the dislocated rod. Balanced saline solution was injected, with a successful repositioning of the implant into the vitreous cavity. Topical 5 % hypertonic saline solution and 0.2 % betamethasone associated with 0.5 % chloramphenicol drops were administered four times a day. To prevent redislocation of the Ozurdex implant, she was instructed to avoid prone position, any kind of physical effort, and not to undertake long-distance flights during the first postoperative week. One week after surgery, an anterior segment examination showed an improvement of corneal edema. Funduscopy showed that the Ozurdex implant was settled into the vitreous cavity. Conclusions: Anterior chamber dislocation of Ozurdex from the vitreous cavity is rare. In our patient, in addition to the posterior capsule tearing, the long-distance flight could have contributed to implant dislocation. Repositioning of the implant is necessary to avoid endothelial decompensation. It can be carried out by using saline balanced solution with the same efficacy as other surgical procedures reported in the literature. A possible disadvantage of this procedure could be implant migration. © 2016 The Author(s).
引用
收藏
相关论文
共 50 条
  • [1] Dislocation in the anterior chamber of a dexamethasone intravitreal implant
    Cousin, Marie
    Hoffart, Louis
    Baeteman, Christophe
    Matonti, Frederic
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2013, 48 (04): : E62 - E63
  • [2] Management of Anterior Chamber Dislocation of a Dexamethasone Implant
    Thi Lyly Nguyen
    Wolfensberger, Thomas J.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2019, 236 (04) : 412 - 414
  • [3] Management of Anterior Chamber Dislocation of Dexamethasone Implant
    Kishore, Sarita A.
    Schaal, Shlomit
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2013, 21 (01) : 70 - 71
  • [4] 'Boating' Out Migrated Dexamethasone Implant; Surgical Management of Removal of Anterior Chamber Migrated Dexamethasone Intravitreal Implant: A Case Report
    Teo, B. H.
    Safinaz, M. K.
    Mae-Lynn, C. B.
    Amin, A.
    Edward, R.
    Mushawiahti, M.
    MEDICINE AND HEALTH-KUALA LUMPUR, 2018, 13 (02): : 175 - 179
  • [5] Management and Complications of Dexamethasone Intravitreal Implant Migration Into the Anterior Chamber
    Betsch, Devin M.
    Gupta, R. Rishi
    JOURNAL OF VITREORETINAL DISEASES, 2022, 6 (06) : 432 - 436
  • [6] Surgical Management of Anterior Chamber Migration of a Dexamethasone Intravitreal Implant
    Stelton, Christopher R.
    Townsend, Justin
    Peterson, Luke T.
    Khurana, Rahul N.
    Yeh, Steven
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (07): : 756 - 759
  • [7] Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration
    D. Röck
    K. U. Bartz-Schmidt
    T. Röck
    BMC Ophthalmology, 19
  • [8] Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration
    Roeck, D.
    Bartz-Schmidt, K. U.
    Roeck, T.
    BMC OPHTHALMOLOGY, 2019, 19 (1)
  • [9] Anterior chamber migration of a dexamethasone implant: a case report
    Berisha, Bujar
    Hoeflechner, Lukas
    Wedrich, Andreas
    SPEKTRUM DER AUGENHEILKUNDE, 2021, 35 (02) : 83 - 87
  • [10] Migration of an intravitreal dexamethasone implant into the anterior chamber in contact with an anterior chamber intraocular lens
    Callet, M.
    Sampo, M.
    Hugo, J.
    Speybrouck-Grebert, A.
    Hoffart, L.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2018, 41 (03): : E107 - E109